SDIC Venture Capital Leads $76M Round In Chinese Innovative Drug Developer Zensun

Login to View

SDIC Venture Capital Management, a subsidiary of State Development & Investment Corp (SDIC), has led a new funding round worth up to RMB507 million (US$76 million) in Zensun (Shanghai) Sci & Tech Co., Ltd., a biopharmaceutical company listed on the ChiNext board in Shenzhen.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in